“Breast on a Chip” could detect very early breast cancer
Illuminating breast cancer cells with nanoparticles could allow tumours to be detected 10 times earlier than current methods, say scientists at Purdue Center for Cancer Research in the USA.
Sophie Lelièvre and James Leary, both from the School of Veterinary Medicine, have modelled the complex mammary duct system to test how nanoparticles injected through the nipple could be guided by magnetic fields to deeply situated cancer cells for detection or treatment.
“Breast cancer is the most common cancer in women in most countries, and we’ve known that the best way to detect this cancer early and treat it effectively would be to get inside the mammary ducts to evaluate and treat the cells directly” said Lelièvre
Previously doctors have attempted to reach the mammary ducts by injecting fluids into the nipple, but this only allowed them to access the first 30% of the breast tissue due to fluid pressure inside the ducts.
Nanoparticles can overcome this problem, says Leary. “The idea is that nanoparticles with a magnetic core can float through the naturally occurring fluid in the ducts and be pulled by a magnet as opposed to being pushed with pressure,” he said.
“We think they could reach all the way to the back of the ducts, where it is believed most breast cancers originate.”
Lelièvre and Leary’s laboratory model is an early step in opening up research into the use of nanoparticles in breast cancer.
Breast cancer cells grown on a flat model could not effectively mimic the three dimensional duct system, which at its smallest, has ducts that are only the diameter of a human hair.
Only nanotechnology has allowed the building of a model small enough, yet precise enough to allow researchers to see what will happen to nanoparticles in a real human breast, and the team are hopeful that in the future this research will translate into clinical applications for the early treatment and detection of breast cancer.
“Although we are at the very beginning stages of this work, we are hopeful that this nanomedical approach will one day save lives and provide patients with an easier road to recovery,” Lelièvre says.
“The successful creation of this model is an important milestone in this work and it is a testament to what can be accomplished through multidisciplinary research.”












